Stephen K. Brannan Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

Stephen K. Brannan is Chief Medical Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2022, when has been sold 10,228 shares (Common Stock) at a price of $7.33 per share, resulting in proceeds of $74,971. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Stephen K. Brannan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2022
BUY
Exercise of conversion of derivative security
$74,971 $7.33 p/Share
10,228 Added 25.28%
30,228 Common Stock
Dec 30 2021
SELL
Bona fide gift
-
15,000 Reduced 66.67%
7,500 Common Stock
Dec 01 2021
SELL
Open market or private sale
$985,861 $127.57 p/Share
7,728 Reduced 27.87%
20,000 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
$65,050 $6.36 p/Share
10,228 Added 26.95%
27,728 Common Stock
Nov 01 2021
SELL
Open market or private sale
$1,056,186 $136.67 p/Share
7,728 Reduced 30.63%
17,500 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$61,982 $6.06 p/Share
10,228 Added 28.93%
25,125 Common Stock
SKB

Stephen K. Brannan

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX